Our Pricing

Mounjaro 7.5mg Price UK: Complete Treatment Guide

Searching for transparent mounjaro 7.5mg price uk online information? At Cured Pharmacy, Mounjaro 7.5mg KwikPens start from £135.00, with £10 off your first order—backed by UK-registered prescribers, genuine MHRA-licensed medication, and discreet next-day delivery. Every treatment begins with a free online consultation completed in under three minutes, ensuring you receive safe, personalised care from our clinical team led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

How Mounjaro 7.5mg Works for Weight Loss

Mounjaro 7.5mg contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing enhanced effects on appetite regulation, insulin secretion, and energy expenditure.

The 7.5mg dose represents the second maintenance level in the Mounjaro titration schedule, typically prescribed after patients complete four weeks on the 2.5mg starter dose and four weeks on the 5mg dose [2]. This gradual escalation minimises gastrointestinal side effects whilst allowing your body to adjust to the medication's appetite-suppressing effects. In the SURMOUNT-1 trial, participants receiving tirzepatide achieved an average body weight reduction of 15% to 22.5% over 72 weeks, depending on final dose—significantly superior to placebo and historical comparators [1].

Mounjaro works by slowing gastric emptying, reducing hunger signals in the brain, and improving your body's insulin response after meals. Patients typically report feeling fuller for longer periods, experiencing fewer cravings, and naturally consuming smaller portion sizes without the constant preoccupation with food that often accompanies traditional calorie-restriction diets [3]. All prescription weight loss treatments, including Mounjaro, require ongoing clinical assessment by a UK prescriber and work most effectively when combined with a reduced-calorie diet and increased physical activity.

Mounjaro 7.5mg Price UK: What You're Paying For

At Cured Pharmacy, Mounjaro 7.5mg is priced at £135.00 per four-week supply, with £10 off your first order—representing exceptional value compared to typical market rates for this advanced dual-agonist therapy. Our transparent pricing model means you see the exact cost before completing your free clinical consultation, with no hidden fees, membership charges, or surprise costs at checkout.

Your Mounjaro prescription includes genuine UK-licensed KwikPens manufactured by Eli Lilly, each pre-filled pen delivering four once-weekly 7.5mg doses with the integrated needle system. Every order is dispensed by our GPhC-registered pharmacy (9012511), reviewed by UK-qualified prescribers, and delivered in 100% discreet packaging via tracked courier service. Unlike some online providers, we include unlimited prescriber messaging support throughout your treatment, allowing you to report side effects, ask dosing questions, or request dose adjustments without additional consultation fees.

The cost reflects not just the medication itself, but comprehensive clinical oversight that matches or exceeds traditional GP-led care. Our prescribers assess your full medical history, current medications, cardiovascular risk factors, and weight loss goals before determining whether Mounjaro 7.5mg is appropriate for your individual circumstances. Patients with certain conditions—including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease—may not be suitable candidates and will be advised of safer alternatives during the assessment process.

Understanding Mounjaro 7.5mg Cost Compared to Other Doses

Mounjaro is available in five maintenance doses: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg, with pricing varying according to dose strength. The 7.5mg dose sits in the mid-range of the titration schedule and is often where patients begin to see substantial weight loss results whilst maintaining tolerable side effect profiles. Your prescriber may recommend staying at 7.5mg long-term if you're achieving your weight loss targets, or may suggest escalating to 10mg, 12.5mg, or 15mg if additional weight reduction is clinically appropriate and you're tolerating the current dose well. Pricing remains competitive across all dose strengths at Cured Pharmacy, with the same transparent, upfront cost structure applied to every prescription.

Mounjaro 7.5mg vs Wegovy: Clinical Comparison

Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are once-weekly injectable treatments licensed by the MHRA for chronic weight management, but they differ substantially in mechanism, efficacy data, and side effect profiles. Wegovy activates only GLP-1 receptors, whilst Mounjaro's dual GIP/GLP-1 action produces greater average weight loss in head-to-head comparisons [4].

In the SURPASS-2 trial, which directly compared tirzepatide to semaglutide 1mg (the same active ingredient as Wegovy's maximum dose), tirzepatide-treated patients achieved significantly greater HbA1c reduction and body weight loss at all dose levels [4]. At the 7.5mg tirzepatide dose specifically, patients lost an average of 9.5kg compared to 5.7kg with semaglutide 1mg over 40 weeks. The highest tirzepatide doses (15mg) produced average weight reductions exceeding 12kg in the same timeframe.

Gastrointestinal side effects—particularly nausea, vomiting, and diarrhoea—occur with both medications but tend to be dose-dependent and diminish over time as your body adjusts. Some patients tolerate one medication better than the other, making individual clinical assessment essential. Wegovy may be more appropriate for patients seeking a lower starting price point or those who've previously responded well to liraglutide (Saxenda), whilst Mounjaro may suit patients seeking maximum efficacy or those who haven't achieved adequate results with GLP-1-only treatments.

Switching Between Mounjaro and Wegovy

Patients can switch between tirzepatide and semaglutide under prescriber guidance, though there's no established direct dose equivalence between the two medications. If you're currently taking Wegovy and considering Mounjaro 7.5mg, your prescriber will typically restart the Mounjaro titration schedule at 2.5mg to minimise side effects, even if you're tolerating a high Wegovy dose. Conversely, switching from Mounjaro to Wegovy usually involves starting Wegovy at the 0.25mg dose and following its standard escalation protocol. Never switch between weight loss medications without explicit prescriber approval, as overlapping GLP-1 therapies can increase hypoglycaemia risk and gastrointestinal adverse events.

How to Use Mounjaro 7.5mg KwikPen Correctly

Mounjaro 7.5mg is administered as a subcutaneous injection once weekly, on the same day each week, at any time of day regardless of meals. Each KwikPen is pre-filled with four doses and uses an integrated needle system—you don't need to attach separate needles or draw up medication from vials. The pen delivers a fixed 7.5mg dose with each injection, eliminating dosing errors common with manual syringe systems.

Inject into the abdomen (at least 5cm away from your navel), front of the thigh, or back of the upper arm, rotating injection sites each week to prevent lipodystrophy (lumpy skin changes). Clean the injection site with an alcohol wipe, remove the pen cap, press the pen firmly against your skin until you hear a click, then hold in place for 10 seconds whilst the medication is delivered. A second click indicates the injection is complete. Dispose of used pens in a sharps container—never in household waste.

If you miss a dose and it's been less than four days since your scheduled injection day, take the missed dose as soon as you remember, then resume your normal weekly schedule. If more than four days have passed, skip the missed dose entirely and take your next dose on the regularly scheduled day [2]. Taking two doses within three days of each other increases the risk of severe nausea and vomiting. Store unused pens in the refrigerator at 2°C to 8°C, and never freeze. Once in use, pens can be kept at room temperature (up to 30°C) for up to 21 days.

Mounjaro 7.5mg Side Effects and Safety Information

The most common side effects of Mounjaro 7.5mg are gastrointestinal: nausea (reported by up to 20% of patients), diarrhoea, vomiting, constipation, abdominal pain, and decreased appetite [1][2]. These effects are typically mild to moderate, occur most frequently during dose escalation, and diminish substantially after 4-8 weeks of continuous use. Eating smaller meals, avoiding high-fat foods, and staying well-hydrated can help manage these symptoms.

Serious but rare adverse events include pancreatitis (inflammation of the pancreas), gallbladder disease, acute kidney injury secondary to dehydration, and severe allergic reactions. Seek immediate medical attention if you experience severe persistent abdominal pain radiating to your back, yellowing of skin or eyes, difficulty breathing, or severe swelling of the face or throat. Mounjaro carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [2]. You should not use Mounjaro if you or any family member has a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Hypoglycaemia (low blood sugar) is uncommon with Mounjaro when used alone for weight loss, but risk increases if you're taking other diabetes medications such as insulin or sulfonylureas. Symptoms include shakiness, sweating, confusion, rapid heartbeat, and dizziness—treat immediately with fast-acting carbohydrates like glucose tablets or fruit juice. Mounjaro may slow the absorption of oral medications taken simultaneously; if you take oral contraceptives, consider using additional barrier contraception for four weeks after starting treatment or increasing doses. All patients should be counselled on the risk of suicidal thoughts and behaviours, which have been reported with GLP-1 receptor agonists, though causality remains uncertain [5].

Who Should Not Use Mounjaro 7.5mg

Mounjaro is contraindicated in patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, previous serious hypersensitivity to tirzepatide, and during pregnancy or breastfeeding. Women of childbearing potential should use effective contraception during treatment and discontinue Mounjaro at least two months before a planned pregnancy, as GLP-1 receptor agonists may cause foetal harm [2]. Patients with severe gastrointestinal disease, including gastroparesis or inflammatory bowel disease, may experience worsening symptoms and should discuss alternative weight loss options with their prescriber. Your UK clinical assessment will identify any contraindications before a prescription is issued.

Getting Your Mounjaro 7.5mg Prescription from Cured Pharmacy

Starting Mounjaro 7.5mg treatment at Cured Pharmacy takes under five minutes from start to delivery. Begin by completing our free online clinical questionnaire, which collects your medical history, current medications, weight loss goals, previous weight loss attempts, and relevant health conditions. Our UK-registered prescribers review every submission individually—there are no automatic approvals or algorithm-based decisions.

If Mounjaro 7.5mg is clinically appropriate for you, your prescription is issued electronically and sent directly to our GPhC-registered pharmacy for dispensing. Most patients begin treatment with the 2.5mg starter dose for four weeks, escalate to 5mg for four weeks, then move to 7.5mg as the first true maintenance dose—though your prescriber may adjust this schedule based on your tolerance and response. Your medication is dispatched via tracked courier in plain, discreet packaging with no external pharmacy branding, typically arriving within 24 hours for orders placed before 3pm on weekdays.

Ongoing prescriptions are managed through your secure patient account, where you can request repeat supplies, report side effects, ask clinical questions, or request dose adjustments without additional consultation fees. Our prescribers provide unlimited messaging support throughout your treatment journey, ensuring you receive the same continuity of care you'd expect from traditional GP-led weight management programmes. Every prescription is subject to ongoing clinical review—if your prescriber determines Mounjaro is no longer appropriate due to side effects, lack of efficacy, or changing health status, alternative treatments will be discussed and recommended.

Next Steps: Start Your Free Consultation Today

Ready to begin your weight loss journey with Mounjaro 7.5mg? Click 'Start Assessment' to complete your free clinical consultation now. You'll receive a prescriber decision within hours, transparent pricing before payment, and discreet delivery to your door. Our team is available on (+44) 116 4646009 if you have questions before starting your assessment. All treatments are subject to clinical approval by a UK-registered prescriber and dispensed by our GPhC-registered pharmacy (9012511) under the oversight of Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Electronic Medicines Compendium. (2024). Mounjaro 7.5 mg solution for injection in pre-filled pen – Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14298
3. Frias, J. P., et al. (2021). Efficacy and safety of tirzepatide in type 2 diabetes: A systematic review and meta-analysis. Diabetes, Obesity and Metabolism, 23(S3), 31–41. https://doi.org/10.1111/dom.14459
4. Frías, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
5. Medicines and Healthcare products Regulatory Agency. (2023). GLP-1 receptor agonists: reports of suicidal and self-injurious thoughts and behaviours. Drug Safety Update, 17(3). Retrieved from https://www.gov.uk/drug-safety-update

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and lifestyle changes. Mounjaro is a prescription-only medicine and is subject to availability and clinical suitability as determined by a UK prescriber.